CORRESP 1 filename1.htm

LAVA Medtech Acquisition Corp.

303 Wyman Street, Suite 300

Waltham, MA 02451

 

October 22, 2021

 

VIA EDGAR

 

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Attention: Melanie Singh and James Lopez

 

  Re: LAVA Medtech Acquisition Corp.
    Registration Statement on Form S-1, as amended
    Filed October 1, 2021
    File No. 333-259983

 

Dear Melanie Singh and James Lopez:

 

Pursuant to Rule 461 under the Securities Act of 1933, as amended, LAVA Medtech Acquisition Corp. hereby requests acceleration of effectiveness of the above referenced Registration Statement so that it will become effective at 4:00 p.m. EST on Tuesday, October 26, 2021, or as soon as thereafter practicable.

 

  Very truly yours,
   
  /s/ Anthony Natale
  Anthony Natale
  Chief Executive Officer

 

cc: Reed Smith LLP
Skadden, Arps, Slate, Meagher & Flom LLP